Cargando…
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science China Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518094/ https://www.ncbi.nlm.nih.gov/pubmed/32975722 http://dx.doi.org/10.1007/s11427-020-1813-0 |
_version_ | 1783587340450529280 |
---|---|
author | Meng, Xiao Liu, Ya Wei, Chenchen Zhang, Kai Zhang, Yi Zhong, Ming Zhang, Cheng Zhang, Yun |
author_facet | Meng, Xiao Liu, Ya Wei, Chenchen Zhang, Kai Zhang, Yi Zhong, Ming Zhang, Cheng Zhang, Yun |
author_sort | Meng, Xiao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7518094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Science China Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-75180942020-09-28 Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension Meng, Xiao Liu, Ya Wei, Chenchen Zhang, Kai Zhang, Yi Zhong, Ming Zhang, Cheng Zhang, Yun Sci China Life Sci Letter to the Editor Science China Press 2020-09-21 2021 /pmc/articles/PMC7518094/ /pubmed/32975722 http://dx.doi.org/10.1007/s11427-020-1813-0 Text en © Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Meng, Xiao Liu, Ya Wei, Chenchen Zhang, Kai Zhang, Yi Zhong, Ming Zhang, Cheng Zhang, Yun Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension |
title | Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension |
title_full | Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension |
title_fullStr | Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension |
title_full_unstemmed | Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension |
title_short | Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension |
title_sort | angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe covid-19 and hypertension |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518094/ https://www.ncbi.nlm.nih.gov/pubmed/32975722 http://dx.doi.org/10.1007/s11427-020-1813-0 |
work_keys_str_mv | AT mengxiao angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT liuya angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT weichenchen angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT zhangkai angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT zhangyi angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT zhongming angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT zhangcheng angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension AT zhangyun angiotensinconvertingenzymeinhibitorsandangiotensinreceptorblockersimprovedtheoutcomeofpatientswithseverecovid19andhypertension |